 Provider News CaliforniaNovember 1, 2024 November 2024 Provider Newsletter Featured Articles Education & Training | Medicaid | September 27, 2024 Education & Training | Medicare Advantage | October 15, 2024 Quality Management | Medicaid | November 1, 2024 Quality Management | Commercial / Medicare Advantage / Medicaid | October 24, 2024 Administrative | Commercial | October 23, 2024 Education & Training | Medicaid | October 17, 2024
CABC-CDCRCM-070441-24 HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). The Department of Health & Human Services (HHS) requires health plans to report whether or not our in-network providers offer telehealth services. If you provide telehealth services, please tell us by submitting your information to us through Availity.com. Updating your telehealth status will not affect your participation with us. We will add a telehealth indicator to your online provider directory profile, allowing our members to know you offer telehealth services. If you have questions about submitting your information, please see the instructions below. If your organization is not currently registered with Availity, you will need to create an account. The person(s) designated as your administrator(s) should go to Availity.com and select Get Started in the upper right corner of the webpage. You may also navigate directly to Availity’s registration website by selecting here. Begin your application here. To update your application: - Log in to Availity Essentials.
- Select My Providers.
- Select Provider Data Management.
Please update your telehealth information at the service location. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CM-069887-24-CPN69222 Balance billing Medi-Cal Managed Care beneficiaries is prohibited by federal and state law. Medi-Cal beneficiaries should not pay physician visits and other medical care when they receive covered services from a provider in their provider network. This means beneficiaries cannot be charged for co-pays, co-insurance, or deductibles. This applies to both Medicare and Medi-Cal providers. Billing Medi-Cal beneficiaries violates federal law as outlined in section 1902(n)(3)(B) of the Social Security Act, as modified by section 4714 of the Balanced Budget Act of 1997. This section of the act is available at: http://www.ssa.gov/OP_Home/ssact/title19/1902.htm. Protections are also found in California Welfare and Institutions Code section 14019.4. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-070223-24 Community Supports (CS) are a menu of services that, at the option of a managed care plan and a member, can substitute for covered Medi-Cal Managed Care services as medically appropriate and cost-effective alternatives. Anthem offers all 14 CS services the Department of Health Care Services (DHCS) has approved for individuals with complex physical behavior, developmental, and social needs. A member who meets the criteria of any of the CS services below is eligible: - Housing/homelessness:
- Housing transition navigation services
- Housing deposits
- Housing tenancy and sustaining
- Day habilitation
- Facilities:
- Short-term post-hospitalization housing
- Recuperative care (medical respite)
- Sobering center
- In-home supports:
- Respite services (can also be provided in a facility setting)
- Personal care and homemaker services
- Nursing homes:
- Nursing facility (NF) transition/diversion to assisted living facilities
- Community transition services/NF transition to a home
- Construction (two services):
- Environmental accessibility adaptations (home modifications)
- Asthma remediation
- Meals:
- Meals/medically tailored meals
We are committed to helping patients more easily access the care they need. For more information, visit our website. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-067848-24 We are pleased to announce our new Pathway HMO fee-for-service network design, Direct HMO. Direct HMO is a grouping of PPO physicians from which members can select a PCP. It applies only to the individual exchange network, Pathway HMO. Read on to learn more about Direct HMO: - Direct HMO rolls out on January 1, 2025.
- Plan members receive an ID card with Pathway HMO at the bottom right and Direct HMO in the center. Members can also access these cards virtually through the SydneySM Health app.
- The network services the following California counties: Fresno, Kings, Los Angeles, Madera, Orange, Riverside, San Bernardino, and San Diego.
- You can access our online directory, Find Care, at anthem.com/ca to find providers in our Direct HMO network.
- Referrals are required for specialty care except for behavioral health services and other services specified in the member’s Pathway HMO health benefit plan, which members can access directly without a referral (for example, reproductive or sexual health care services and obstetrical/gynecological care consultations as described in the member’s Evidence of Coverage for complete benefit information). Make sure to refer only within the extensive network of Direct HMO specialists.
- For our members with an assigned PCP in Direct HMO, we require all participating plan care providers to follow specific Utilization Management (UM) requirements:
- Promptly notify us of all referral and authorization requests.
- Collaboration with our HMO Clinical Ops Team ensures timely and effective coordination of members’ care needs and guidance to the right in-network care providers.
Questions: - For specific contract questions, email SpecialNetworkReq@anthem.com with Direct HMO in the subject line.
- For UM or medical management questions, contact our HMO Clinical Ops team. Call toll-free
866-757-8211, fax to 866‑461‑2401, or email hmocomanagement@anthem.com. Please limit questions to medical management only. - For general inquiries, contact our Provider Relations department. For more contact options, please visit anthem.com/ca > Contact Us.
- Our FAQ provides general information about Direct HMO and answers common questions. It will be updated as needed. Please refer to the attached FAQ for details.
We are committed to finding solutions that help our care provider partners offer quality services to our members. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CM-070340-24-SRS70340, CABC-CM-070538-24-SRS70340 ATTACHMENTS (available on web): Direct HMO, applicable to Pathway HMO network, effective January 1, 2025 FAQ (pdf - 0.04mb) Participating providers are responsible for offering members access to covered services 24/7. Access includes regular office hours on weekdays and the availability of a provider or designated agent by telephone after regular office hours, on weekends, and on holidays. When unavailable, providers must arrange for on-call coverage by another participating provider. Providers are also required to meet appointment access standards as described below.
After-hours calls:
- Providers must instruct their after-hours answering service to answer Anthem’s After Hours Survey questions. Non-compliant providers are subject to contractual enforcement actions, such as Corrective Action Plans (CAP) or escalated contractual sanctions for breach of contract.
- The answering service or after-hours personnel must ask the member if the call is an emergency. In the event of an emergency, the member must be immediately directed to dial 911 or to proceed directly to the nearest hospital emergency room.
- If staff or answering service is not immediately available, an answering machine may be used. The answering machine message must instruct members with emergency healthcare needs to dial 911 or go directly to the nearest hospital emergency room. The message must also give members an alternative contact number so they can reach the primary care physician (PCP) or on-call provider with medical concerns or questions.
- Non-English-speaking members who call their PCP after hours should expect to get
language-appropriate messages. In the event of an emergency, these messages should direct the member to dial 911 or proceed directly to the nearest hospital emergency room.
- In a non-emergency situation, members should receive instruction on how to contact the on-call provider. If an answering service is used, the service should know where to contact a telephone interpreter. All calls taken by an answering service must be returned.
Appointment access
Note: The next available appointment date and time can be either in-person or by telehealth services.
Healthcare providers must make appointments for members from the time of request as follows:
General appointment scheduling
|
Emergency examination
|
Immediate access, 24/7
|
Urgent (sick) examination
|
Within 48 business hours of request if authorization is not required or within 96 business hours of request if authorization is required, or as clinically indicated
|
Routine primary care examination (non‑urgent)
|
Within 10 business days of request
|
Non-urgent consults/specialty referrals
|
Within 15 business days of request
|
Non-urgent care with non-physician mental health provider or substance use disorder (SUD) provider (where applicable)
|
Within 10 business days of request
|
Non-urgent follow-up care with non-physician mental health provider or SUD provider
|
Within 10 business days of request
|
Non-urgent ancillary
|
Within 15 business days of request
|
Mental health appointment, non-physician
|
Within 10 business days of request
|
SB221 — Effective since July 1, 2022, non-physician mental health/SUD appointments are subject to the timely access standards outlined in the chart above. This bill also requires that all health plans ensure that enrollees who are undergoing a course of treatment for an ongoing mental health or SUD condition can schedule a follow up appointment with their non-physicians mental healthcare or SUD provider within 10 business days of the prior appointment.
Services for members under the age of 21 years
|
Initial health assessments
|
Children from birth to 20 years of age
|
Within 120 days of enrollment
|
Preventive care visits
|
Within 14 days of request
|
Services for members 21 years of age and older
|
Initial health assessments
|
Within 120 days of enrollment
|
Preventive care visits
|
Within 14 days of request
|
Routine physicals
|
Within 30 days of request
|
Prenatal and postpartum visits
|
First and second trimester
|
Within seven days of request
|
Third trimester
|
Within three days of request
|
High-risk pregnancy
|
Within three days of identification
|
Postpartum
|
Between 7 and 84 days after delivery
|
Long-term services and supports
|
Skilled nursing facility
|
- Rural and small counties — within 14 business days of request
- Medium counties — within seven business days of request
- Dense counties — within five business days of request
|
Intermediate care facility/developmentally disabled (ICF-DD)
|
- Rural and small counties — within 14 business days of request
- Medium counties — within seven business days of request
- Dense counties — within five business days of request
|
Community-based adult services (CBAS)
|
Capacity cannot decrease in aggregate statewide below April 2021 level
|
Specialists
The following guidelines are in place for our specialists:
- For urgent care, the specialist should see the member within 96 hours of receiving the request.
- For routine care, the specialist should see the member within 15 business days of receiving the request.
- A copy of the medical records and/or results of the visit should be sent to the PCP’s office to allow continuity of care.
Wait times
When a provider's office receives a call from an Anthem member during regular business hours — as well as after hours — for assistance and possible triage, the provider or another healthcare professional must either take the call or call the member back within 30 minutes of the initial call.
When an Anthem member arrives on time to an appointment, the member should be seen within 15 minutes of the scheduled appointment.
When Anthem members and/or prospective members call a physician’s office, they should not be placed on hold for longer than 10 minutes.
Interpretation services
When a provider’s office receives a call from an Anthem member, the provider’s office should know where to contact a telephone interpreter to communicate in the member’s preferred language.
Noncompliance
Ensure that you comply with the standards described; compliance with these standards is a contractual requirement. Anthem monitors compliance through a number of mechanisms, including annual telephonic surveys, to determine if participating provider offices meet the above standards.
For additional details, review the provider manuals at
https://providers.anthem.com/california-provider/resources/manuals-policies-guidelines.
Beginning in 2023, delegated network providers will be measured based on a compliance threshold of 70% as outlined in CCR 1300.67.2.2. Delegates scoring below 70% compliance for Non-Urgent and Urgent appointment availability will be subject to corrective action, up to and including, termination of the contract.
Required timely access training course — to be released in measurement year 2024
Rescheduling missed appointments — Los Angeles county providers only
Missed appointments
|
Standard
|
The time after a missed appointment that a patient is contacted to reschedule their appointment
|
48 hours
|
This is a reminder that Los Angeles county providers are required to call to reschedule an appointment within 48 hours after a missed appointment. Ensure your office’s policies and procedures and training are updated to include this requirement. Providers may be surveyed on a random sample to ensure compliance with this standard.
Schedule of timely access surveys
Provider Appointment Availability Survey (PAAS):
- Survey subject(s): Appointment availability
- Managed Care Plan: Anthem
- Contractor conducting survey: Sutherland
- Regulatory agency: Department of Managed Health Care (DMHC)
- Schedule: July through November 2024
After Hours and Appointment Availability Survey:
- Survey subject(s): Emergency and urgent after-hours calls
- Managed Care Plan: Anthem
- Contractor conducting survey: TBD
- Regulatory agency: National Committee for Quality Assurance (NCQA); DMHC
- Schedule: October through November 2024
Primary Care and Specialty Care Appointment Availability Survey:
- Survey subject(s): Appointment availability, interpretation services
- Conducting/regulatory agency: Department of Health Care Services (DHCS)
- Schedule:
- Q1: January through March
- Q2: April through June
- Q3: July through September
- Q4: October through December
DHCS administers the surveys, and Anthem is provided the surveys after each quarter.
Non-compliant providers are subject to contractual enforcement actions, such as Corrective Action Plans (CAP) or escalated contractual sanctions for breach of contract. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. CABC-CDCM-050906-24, CABC-CDCM-060259-24, CABC-CDCM-070100-24 In July, we announced an enhancement to the 277CA to notify you of submission errors discovered during claims processing (https://tinyurl.com/774zs7j7). As of November 1, 2024, the 277CA will include additional corrective action types for your review. As communicated in July, these errors will still be sent through physical mailing. With these added error types, there is no reduction to the services we already provide. Through our efforts, we are committed to reducing administrative burden, improving communication, and ensuring timely payments because we value you, our care provider partners. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CM-069543-24-CPN69313 Find Care, the doctor finder and transparency tool in the Anthem online directory, provides Anthem members with the ability to search for in-network providers using the secure member website. This tool currently offers multiple sorting options such as sorting providers based on distance, alphabetical order, and provider name. In our November 2022 newsletter, we provided an update regarding Personalized Match, an additional Find Care sorting option for Commercial members. We informed you that this provider sorting option was based on provider efficiency and quality outcomes described in a methodology document linked in the newsletter article, in addition to member search radius. We want to inform you that, beginning in December 2024 or later, we will be enhancing Personalized Match. This will expand upon the existing program. Newer components of the provider personalization metrics will contain up to 10 times as many features as compared to existing metrics such as gaps in care, and additional types of service cost and utilization. Personalized Match will continue to display providers with the highest overall ranking within the member’s search radius, first. Members will continue to have the ability to sort based on distance, alphabetical order, and provider name. Helpful resources on AvailityYou may review a copy of the Personalized Match methodology that has been posted on Availity, our secure web-based provider tool, using the following navigation: - Go to Availity > Payer Spaces > Health Plan > Education & Reference Center > Administrative Support > Personalized Match Methodology.pdf.
If you have general questions regarding these upcoming changes, please submit an inquiry via the web at Availity.com. If you would like information about your quality or efficiency scoring used as part of this sorting option or if you would like to request reconsideration of those scores, you may do so by submitting an inquiry to Availity.com. Anthem will continue to focus and expand our consumer tools and content to assist members in making more informed and personalized healthcare decisions. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CM-061239-24, CABC-CM-070200-24 This notice serves as a reminder of what to do if a provider who is part of the Anthem Blue Cross network terminates their contract, changes location, or changes the population they serve. This applies to both primary care physicians (PCPs) and all specialists. Please adhere to the following guidelines:- The provider should notify Anthem within a minimum of 120 calendar days to ensure timely member notifications can be sent.
- The provider's termination and/or changes will become effective no less than 120 calendar days after the notification is received.
The provider's decision to terminate from Anthem could impact participation in other Anthem lines of business and may prevent the provider from participating with Anthem in the future. This is a contractual requirement. It is imperative that these minimum timelines are met to ensure members, the California Department of Health Care Services (DHCS), and the health plan are notified as required, ensuring systems are updated in a timely manner. Future instances of untimely notification may result in the issuance of a Corrective Action Plan, including but not limited to financial sanctions and/or a breach of contract notice. Additional details and information can be found in the provider manual, available online at https://providers.anthem.com/ca > Resources > Provider Manuals, Policies & Guidelines > Medi-Cal Managed Care and Major Risk Medical Insurance Program Provider Manual. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-068313-24 As a contracted provider for a special needs plan (SNP) from Anthem, you are required to participate in an annual Model of Care training for providers, per CMS regulations. This training includes a detailed overview of Anthem special needs plans and program information, highlighting cost sharing, data sharing, participation in the Interdisciplinary Care team (ICT), where to access the member’s health risk assessment results, plan of care, and benefit coordination. Please remember this training is specific to our plans and delivery of care for members, ensuring their specific care needs are met. Your participation is critical for improved quality and health outcomes. Training for the SNP product is self-paced and available at Availity.com. The training must be completed by December 31, 2024. How to access the Custom Learning Center:- Log in to the Availity website at Availity.com.
- At the top of the Availity website, select Payer Spaces and select the appropriate payer.
- On the Payer Spaces landing page, select Access Your Custom Learning Center from Applications.
- In the Custom Learning Center, select Required Training.
- Select Special Needs Plan and Model of Care Overview.
- Select Enroll.
- Select Start.
- Once the course is completed, select Begin Attestation and complete.
Not registered for Availity Essentials?Have your organization’s designated administrator register your organization for the Availity website: - Visit Availity.com to register.
- Select Register.
- Select your organization type.
- In the Registration wizard, follow the prompts to complete the registration for your organization.
Refer to these PDF documents for complete registration instructions. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CR-070558-24-CPN70218 As respiratory syncytial virus (RSV) season approaches, we would like to remind providers about available RSV immunizations to help prevent severe RSV related disease in infants. According to a report from the CDC (March 2024), infant preventive antibodies showed 90% effectiveness against the need for hospitalization for RSV in babies. Two immunizations are available to prevent RSV lower respiratory tract infections in infants: - Pfizer's Abrysvo, a maternal vaccine given during pregnancy
- Nirsevimab (Beyfortus), a monoclonal antibody administered to the baby
The maternal vaccine, Abrysvo, is recommended for those who are 32 to 36 weeks pregnant during RSV season, which generally falls between October and March. The vaccine can provide protection for infants up to six months if the mother receives it at least two weeks prior to delivery. Nirsevimab (Beyfortus) provides up to five months of protection against RSV and is approved for infants under 8 months during their first RSV season, and certain children between 8 and 19 months at increased risk of severe RSV disease. In some cases where a mother received an RSV vaccine, Nirsevimab can still be considered for the child if there is a substantial risk for severe RSV disease or if the maternal immune response to the vaccination is inadequate. Nirsevimab is covered under the Vaccines for Children Program. Additional information about RSV prevention and Nirsevimab (Beyfortus) can be found at cdc.gov/rsv. We look forward to sharing resources and working with you to achieve improved outcomes for children in our communities. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-068126-24-CPN67753 A key goal of Anthem’s provider transparency initiatives is to improve quality while managing healthcare costs. One of the ways this is done is by giving certain providers (value-based program providers, also known as payment innovation providers) in Anthem’s various value-based programs (for example, Enhanced Personal Health Care,) (the Programs) quality, utilization and/or cost data, reports, and information about the healthcare providers (referral providers) to whom the value-based program providers may be referring, or plan to refer, their patients covered under the programs. If a referral provider is higher quality and/or lower cost, this component of the programs may result in their getting more referrals from value-based program providers. The converse should be true if referral providers are lower quality and/or higher cost. Providing this type of data, including comparative cost information, to value-based program providers helps them make more informed decisions about managing healthcare costs and maintaining and improving quality of care. It also helps them succeed under the terms of the programs. Additionally, employers and group health plans (or their representatives or vendors) may also be given quality/cost/utilization information about value-based program providers and referral providers so that they can better understand how their healthcare dollars are being spent and how their health benefits plans are being administered. This will, among other things, give them the opportunity to educate their employees and plan members about the benefits of using higher quality and/or lower cost health care providers. Anthem will share data on which it relied in making these quality/cost/utilization evaluations upon request and will discuss it with referral providers — including any opportunities for improvement. If you have questions or support, please refer to your provider relationship management representative. We’re committed to active involvement with our care provider partners and going beyond the contract to create a real impact on the health of our communities. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CM-070851-24-SRS70814 At a glance: - The Child Health and Disability Prevention (CHDP) program has been phased out, and services were transitioned to other systems effective July 1, 2024.
- Medi-Cal will handle provider trainings and facility site reviews to ensure compliance with preventive care screenings.
OverviewThe California Department of Health Care Services (DHCS) phased out the (CHDP) program and transitioned services to other delivery systems effective July 1, 2024. This transition simplified and streamlined the delivery of services to children and youth under the age of 21 in alignment with the goals of the CalAIM initiative. Prior to July 1, 2024, the CHDP program included: - Preventive health, vision and dental screening, and care coordination for fee-for-service (FFS) members eligible for Medi-Cal for Kids & Teens, federally known as the early and periodic screening, diagnostic, and treatment (EPSDT) benefit.
- CHDP Gateway, which serves as a presumptive eligibility (PE) entry point for children to receive temporary preventive, primary, and specialty healthcare coverage through the Medi-Cal fee-for-service (FFS) delivery system.
- Responsibility for provider trainings on well-child preventive care screenings that included anthropometric measurements, dental screenings/fluoride varnish application, and audiometric and vision screenings.
- Responsibility for facility and medical record reviews of CHDP program provider sites.
Effective July 1, 2024: - The CHDP programs and EPSDT services are covered in both the FFS and managed care delivery systems.
- PE services will continue and expand under the new children’s presumptive eligibility (CPE) platform, and PE services for individuals over the age of 19 will continue under hospital presumptive eligibility (HPE).
- Managed care plans shall ensure that ongoing provider trainings on well-child preventive care screenings outlined above are conducted.
- Managed care plans shall conduct the facility site and medical record reviews (FSR/MRRs) of former CHDP program providers who are also primary care providers seeing Medi-Cal members during their periodic managed care FSR/MRRs.
Additional information about the CHDP program transition can be found here. Provider trainings and medical record documentationIn an effort to ensure providers comply with required provider trainings and medical record documentation on well-child preventive care screenings, we developed/compiled the following provider resources: Medi-Cal Managed Care for FSR and MRRsDHCS requires managed care plans to conduct initial and subsequent facility and medical record reviews of primary care provider sites to ensure all contracted PCP sites have sufficient capacity to provide appropriate primary healthcare services and can maintain patient safety standards and practices. During the facility site reviews, reviewers shall assess staff competencies on well-child preventive care screenings as part of the CHDP program transition to ensure screenings are done appropriately. Please access the FSR MRR Preparation Checklist for more information on how your clinic can successfully complete managed care reviews. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-068527-24 In the June 2024 edition of Provider News, we announced the transition to the following Carelon Medical Benefits Management guidelines: Site of Care for Advanced Imaging, Rehabilitative Site of Care, and Surgical Site of Care, effective September 1, 2024. To clarify, existing prior authorization requirements have not changed, and this does not equate to the presence of a site of care review requirement. In the event a site of care review requirement for these services will be implemented, a separate notice will be distributed before the addition of any such requirements. You may access and download a copy of the current and upcoming guidelines here. Site of Care Guidelines: - Site of Care for Advanced Imaging
- Rehabilitative Site of Care
- Surgical Site of Care
Please share this notice with other members of your practice and office staff. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CR-067575-24-CPN67268 In the July 2024 edition of Provider News, we announced the transition to the following Carelon Medical Benefits Management guidelines: Site of Care for Advanced Imaging, Rehabilitative Site of Care, and Surgical Site of Care effective September 1, 2024. To clarify, existing prior authorization requirements have not changed, and this does not equate to the presence of a site of care review requirement. In the event a site of care review requirement for these services will be implemented, a separate notice will be distributed before the addition of any such requirements. You may access and download a copy of the current and upcoming guidelines here: - Site of Care Guidelines:
- Site of Care for Advanced Imaging
- Rehabilitative Site of Care
- Surgical Site of Care
Please share this notice with other members of your practice and office staff. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-067584-24-CPN67275 Effective November 17, 2024 This article was updated on November 24, 2024 to change the effective date from October 26, 2024 to November 17, 2024. Effective on November 17, 2024, the following Carelon Medical Benefits Management, Inc. Clinical Appropriateness Guideline updates will be adopted for Anthem. This article is to communicate the plan adoption of these Carelon Medical Benefits Management, Inc. guidelines. Existing prior authorization requirements have not changed. In the event a prior authorization requirement or site of care review requirement for these services will be implemented, a separate notice will be distributed before the addition of any such prior authorization or site of care review requirement. You may access and download a copy of the current and upcoming guidelines here: - Musculoskeletal:
- Site of Care:
- Site of Care for Advanced Imaging
- Rehabilitative Site of Care
- Surgical Site of Care
The above guideline updates have a publish date of November 17, 2024. Please share this notice with other members of your practice and office staff. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CR-065130-24-CPN64434, MULTI-ALL-CR-074348-24 Effective January 30, 2025 Effective on January 30, 2025, the following Carelon Medical Benefits Management, Inc. Clinical Appropriateness Guidelines updates will be adopted for Anthem. This article is to communicate the plan adoption of these Clinical Appropriateness Guidelines. Existing prior authorization requirements have not changed. In the event a prior authorization requirement or site of care review requirement for these services will be implemented, a separate notice will be distributed before the addition of any such prior authorization or site of care review requirement. You may access and download a copy of the current and upcoming guidelines here. - Cardiovascular:
- Implantable Cardioverter Defibrillators
- Genetic Testing:
- Cell-free DNA Testing for the Management of Cancer
- Prenatal Testing using cell-free DNA
- Somatic Tumor Testing
- Musculoskeletal:
- Joint Surgery
- Small Joint Surgery
- Site of Care:
- Site of Care for Advanced Imaging
- Rehabilitative Site of Care
- Surgical Site of Care
The above guideline updates have a publish date of November 17, 2024. Please share this notice with other members of your practice and office staff Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-067222-24-CPN66675 Effective November 23, 2024 The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised during Quarter Two, 2024. Note, several policies and guidelines were revised to provide clarification only and are not included. Some may have expanded rationales, medical necessity indications or criteria, and some may involve changes to policy position statements that might result in services that previously were covered being found to be not medically necessary. Please share this notice with other providers in your practice and office staff. To view a guideline, visit https://anthem.com/ca/provider/policies/clinical-guidelines. Notes/updates:Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive. - MED.00148 - Gene Therapy for Metachromatic Leukodystrophy
- Outlines the Medically Necessary and Not Medically Necessary criteria for gene therapy for metachromatic leukodystrophy
Medical PoliciesOn May 9, 2024, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem. These medical policies take effect November 23, 2024. Publish date | Medical Policy number | Medical Policy title | New or revised | May 16, 2024 | *MED.00148 | Gene Therapy for Metachromatic Leukodystrophy | Revised |
Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CR-068818-24-CPN68231 Effective December 26, 2024 The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised during Quarter Two, 2024. Note, several policies and guidelines were revised to provide clarification only and are not included. Some may have expanded rationales, medical necessity indications, or criteria, and some may involve changes to policy position statements that might result in services that previously were covered being found to be not medically necessary. Please share this notice with other providers in your practice and office staff. To view a guideline, visit Provider Medical Policies | Anthem.com. Notes/updatesUpdates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive: - MED.00055 — Wearable Cardioverter Defibrillators:
- Reformatted language from the to a wearable cardioverter defibrillator and moved punctuation
- Added Not Medically Necessary statement when individual has an automated external defibrillator
- MED.00148 — Gene Therapy for Metachromatic Leukodystrophy:
- Outlines the Medically Necessary and Not Medically Necessary criteria for gene therapy for metachromatic leukodystrophy
- RAD.00069 — Absolute Quantitation of Myocardial Blood Flow Measurement:
- The use of absolute quantitation of myocardial blood flow testing is considered Investigational & Not Medically Necessary for all indications
- SURG.00011 — Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting:
- Revised ocular indications, including the addition of SurSight to Medically Necessary and Not Medically Necessary section and added new Medically Necessary criterion addressing non-healing or persistent corneal epithelial defects
- Removed VersaWrap from Investigational & Not Medically Necessary statement
- Removed Phasix Mesh from Investigational & Not Medically Necessary statement
- Added Phasix Mesh and Phasix ST Mesh to Medically Necessary and Not Medically Necessary statements
- CG-DME-54 — Mechanical Insufflation-Exsufflation Devices:
- Outlines the Medically Necessary and Not Medically Necessary criteria for use of mechanical insufflation-exsufflation devices
Medical PoliciesOn May 9, 2024, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem. These medical policies take effect December 26, 2024. Publish Date | Medical Policy Number | Medical Policy Title | New or Revised | 6/28/2024 | ANC.00009 | Cosmetic and Reconstructive Services of the Trunk, Groin, and Extremities | Revised | 6/28/2024 | *MED.00055 | Wearable Cardioverter Defibrillators | Revised | 5/16/2024 | *MED.00148 | Gene Therapy for Metachromatic Leukodystrophy | Revised | 6/28/2024 | *RAD.00069 | Absolute Quantitation of Myocardial Blood Flow Measurement | New | 6/28/2024 | *SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Revised | 6/28/2024 | SURG.00121 | Transcatheter Heart Valve Procedures | Revised |
Clinical UM GuidelinesOn May 9, 2024, the MPTAC approved the following Clinical UM Guidelines applicable to Anthem. These guidelines were adopted by the medical operations committee for Medicaid members on June 27, 2024. These guidelines take effect December 26, 2024. Publish Date | Clinical UM Guideline Number | Clinical UM Guideline Title | New or Revised | 6/28/2024 | *CG-DME-54 | Mechanical Insufflation-Exsufflation Devices | New | 6/28/2024 | CG-DME-55 | Automated External Defibrillators for Home Use | New | 6/28/2024 | CG-MED-68 | Therapeutic Apheresis | Revised | 6/28/2024 | CG-MED-97 | Biofeedback and Neurofeedback | New |
Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-068644-24-CPN68109 Effective February 1, 2025 Effective February 1, 2025, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem for Medi-Cal Managed Care members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions, take precedence over these PA rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | 0141U | Infectious disease (bacteria and fungi), gram-positive organism identification and drug resistance element detection, DNA (20 gram-positive bacterial targets, 4 resistance genes, 1 pan gram-negative bacterial target, 1 pan Candida target), blood culture, amplified probe technique, each target reported as detected or not detected | 0142U | Infectious disease (bacteria and fungi), gram-negative bacterial identification and drug resistance element detection, DNA (21 gram-negative bacterial targets, 6 resistance genes, 1 pan gram-positive bacterial target, 1 pan Candida target), amplified probe technique, each target reported as detected or not detected | 0321U | Infectious agent detection by nucleic acid (DNA or RNA), genitourinary pathogens, identification of 20 bacterial and fungal organisms and identification of 16 associated antibiotic-resistance genes, multiplex amplified probe technique | 0449T | Insertion of aqueous drainage device, without extraocular reservoir, internal approach, into the subconjunctival space; initial device | 21086 | Impression & Custom Preparation; Auricular Prosthesis | 36468 | Injection(s) of sclerosant for spider veins (telangiectasia), limb or trunk | 36473 | Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, mechanochemical; first vein treated | 37241 | Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; venous, other than hemorrhage (for example, congenital or acquired venous malformations, venous and capillary hemangiomas, varices, varicoceles) | 61885 | Subq Placement Cranial Neurostimulator Pulse Generator/Receiver; W/Connection Sngle Electrod Array | 64568 | Open implantation of cranial nerve (for example, vagus nerve) neurostimulator electrode array and pulse generator | 64569 | Revision or replacement of cranial nerve (for example, vagus nerve) neurostimulator electrode array, including connection to existing pulse generator | 66183 | Insertion of anterior segment aqueous drainage device, without extraocular reservoir, external approach | 66989 | Extracapsular cataract removal with insertion of intraocular lens prosthesis (1-stage procedure), manual or mechanical technique (for example, irrigation and aspiration or phacoemulsification), complex, requiring devices or techniques not generally used in routine cataract surgery (for example, iris expansion device, suture support for intraocular lens, or primary posterior capsulorrhexis) or performed on patients in the amblyogenic developmental stage; with insertion of intraocular (for example, trabecular meshwork, supraciliary, suprachoroidal) anterior segment aqueous drainage device, without extraocular reservoir, internal approach, one or more | 66991 | Extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (for example, irrigation and aspiration or phacoemulsification); with insertion of intraocular (for example, trabecular meshwork, supraciliary, suprachoroidal) anterior segment aqueous drainage device, without extraocular reservoir, internal approach, one or more | 82107 | Alpha-fetoprotein (AFP); AFP-L3 fraction isoform and total AFP (including ratio) | 86304 | Immunoassay, Tumor Antigen, Quantitative; Ca 125 | 95976 | Electronic analysis of implanted neurostimulator pulse generator/transmitter (for example, contact group[s], interleaving, amplitude, pulse width, frequency [Hz], on/off cycling, burst, magnet mode, dose lockout, patient selectable parameters, responsive neurostimulation, detection algorithms, closed loop parameters, and passive parameters) by physician or other qualified health care professional; with simple cranial nerve neurostimulator pulse generator/transmitter programming by physician or other qualified health care professional | 95977 | Electronic analysis of implanted neurostimulator pulse generator/transmitter (for example, contact group[s], interleaving, amplitude, pulse width, frequency [Hz], on/off cycling, burst, magnet mode, dose lockout, patient selectable parameters, responsive neurostimulation, detection algorithms, closed loop parameters, and passive parameters) by physician or other qualified health care professional; with complex cranial nerve neurostimulator pulse generator/transmitter programming by physician or other qualified health care professional | 97760 | Orthotic(s) management and training (including assessment and fitting when not otherwise reported), upper extremity(ies), lower extremity(ies) and/or trunk, initial orthotic(s) encounter, each 15 minutes | 97763 | Orthotic(s)/prosthetic(s) management and/or training, upper extremity(ies), lower extremity(ies), and/or trunk, subsequent orthotic(s)/prosthetic(s) encounter, each 15 minutes | A2026 | Restrata MiniMatrix, 5 mg | A4438 | Adhesive clip applied to the skin to secure external electrical nerve stimulator controller, each | C1734 | Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable) | C9796 | Repair of enterocutaneous fistula small intestine or colon (excluding anorectal fistula) with plug (for example, porcine small intestine submucosa [SIS]) | C9797 | Vascular embolization or occlusion procedure with use of a pressure-generating catheter (for example, one-way valve, intermittently occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction | E0735 | Non-invasive vagus nerve stimulator | E2298 | Complex rehabilitative power wheelchair accessory, power seat elevation system, any type | Q4305 | American Amnion AC Tri-Layer, per sq cm | Q4306 | American Amnion AC, per sq cm | Q4307 | American Amnion, per sq cm | Q4308 | Sanopellis, per sq cm | Q4309 | VIA Matrix, per sq cm | Q4310 | Procenta, per 100 mg |
To request PA, you may use one of the following methods: - Web: Log in to Availity.com.
- Fax: 800-754-4708
- Phone: 888-831-2246 — Medi-Cal, 877-273-4193 — MRMIP
Not all PA requirements are listed here. Detailed PA requirements are available to providers on https://providers.anthem.com/ca on the Resources tab or contracted providers can access Availity.com. Providers may also call Medi-Cal Customer Care Centers for assistance with PA requirements: - Outside L.A. County: 800-407-4627
- L.A. County: 888-285-7801
UM AROW #: A2024M187 Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-065592-24-CPN65118 Effective February 1, 2025 Effective February 1, 2025, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem for Medicare Advantage members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions, take precedence over these precertification rules and must be considered first when determining coverage. Non‑compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Code description | 0456U | Autoimmune (rheumatoid arthritis), next-generation sequencing (NGS), gene expression testing of 19 genes, whole blood, with analysis of anti-cyclic citrullinated peptides (CCP) levels, combined with sex, patient global assessment, and body mass index (BMI), algorithm reported as a score that predicts nonresponse to tumor necrosis factor inhibitor (TNFi) therapy PrismRA®, Scipher Medicine®, Scipher Medicine® | 0459U | β-amyloid (Abeta42) and total tau (tTau), electrochemiluminescent immunoassay (ECLIA), cerebral spinal fluid, ratio reported as positive or negative for amyloid pathology Elecsys® Total Tau CSF (tTau) and β-Amyloid (1-42) CSF II (Abeta 42) Ratio, Roche Diagnostics Operations, Inc (US owner/operator) | 0468U | Hepatology (nonalcoholic steatohepatitis NASH), miR-34a5p, alpha 2-macroglobulin, YKL40, HbA1c, serum and whole blood, algorithm reported as a single score for NASH activity and fibrosis NASHnext™ (NIS4™), Labcorp, Labcorp | J0687 | Injection, cefazolin sodium (WG Critical Care), not therapeutically equivalent to J0690, 500 mg | J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | J2183 | Injection, meropenem (WG Critical Care), not therapeutically equivalent to J2185, 100 mg | J2184 | Injection, meropenem (B. Braun), not therapeutically equivalent to J2185, 100 mg | J2281 | Injection, moxifloxacin (Fresenius Kabi), not therapeutically equivalent to J2280, 100 mg |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on https://anthem.com/ca/provider/medicare-advantage on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call Provider Services at the number on the back of the patient’s member ID card for assistance with PA requirements. UM AROW #: A2024M2186 Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CR-068214-24-CPN67511 Effective retroactively for dates of service on or after November 13, 2023, HCPCS code J9057 (injection, copanlisib 1 mg) is no longer a Medi-Cal Managed Care benefit. In November 2023, manufacturer Bayer, in conjunction with the FDA, began the withdrawal of their Aliqopa (copanlisib) New Drug Application for adult patients with relapsed follicular lymphoma (FL) who have received at least two prior systemic therapies. A confirmatory clinical trial did not meet the primary endpoint of progression-free survival (PFS) benefit versus standard immunotherapy. Aliqopa had been granted accelerated approval by the FDA in September 2017 based on CHRONOS-1, an open-label, single-arm Phase II study. The FDA required clinical benefit to be confirmed through the CHRONOS-4 study. In CHRONOS-4, the addition of Aliqopa to standard immunochemotherapy regimens did not meet the primary endpoint of PFS benefit versus the standard immunochemotherapy control arm in patients with relapsed FL. Bayer intends to publish the results of CHRONOS-4 in a timely manner. Bayer is exploring access options for patients currently receiving Aliqopa who have experienced a favorable response to treatment, whose treating physician supports continuing treatment with Aliqop, and for whom there may be no suitable alternative treatments available. No new patients should be prescribed Aliqopa. For questions related to ongoing access, contact Bayer Medical Communications at 888-842-2937. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-071374-24 Enhanced adherence mitigates healthcare costs and improves patient outcomes and quality of life. Promoting medication adherence and advocating for statin use among diabetes patients is critical. Statin use in diabetes:- Diabetics are two to four times more likely to die from heart disease (American Heart Association).
- Statins lower LDL cholesterol, reducing cardiovascular events by 25 to 60%.
- Statin use is low, particularly in younger, female, and black individuals.
- Delayed statin use increases cardiovascular disease risk in diabetic patients.
- National guidelines recommend statin therapy for diabetics ages 40 to 75, regardless of LDL levels.
- CMS has adopted the Statin Use in Persons with Diabetes (SUPD) measure to combat cardiovascular death in diabetic patients.
Medication adherence:- Poor adherence increases morbidity and mortality, causing more than 125,000 deaths and 10% of hospitalizations annually in the United States.
- Forty-five percent of U.S. adults have hypertension and only 24% manage it effectively, largely due to non-adherence.
- High adherence in diabetic patients reduces hospitalization risks by 30%.
- Improved adherence can save $1,200 to $8,000 per patient annually.
Supporting patients:- Simplify the regimen: Prescribe medications with fewer daily doses.
- Regular follow-ups: Ensure correct medication use and adjust doses as needed.
- Clear communication: Explain medication benefits, risks of non-compliance, and side effects.
- Extended prescriptions: Provide 90 to 100 days’ supply and sufficient refills.
- Home delivery: Eliminate transportation barriers.
- Address statin hesitancy: Discuss pros and cons and involve family in decisions.
- Use technology: Set up reminders through mobile apps, SMS, email, or pill containers.
- Address cost issues: Prescribe affordable options and explore assistance programs.
- Personalized care: Tailor medication plans to the patient's lifestyle and needs.
References: - American Diabetes Association Professional Practice Committee. 10. Cardiovascular disease and risk management: Standards of Care in Diabetes—2024. Diabetes Care 2024;47(Suppl. 1):S179–S218
- Bradley CK, Wang TY, Li S, et al. Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry. Journal of the American Heart Association. 2019;8(7). doi: https://doi.org/10.1161/jaha.118.011765
- Wall HK, Ritchey MD, Gillespie C, Omura JD, Jamal A, George MG. Vital Signs: Prevalence of Key Cardiovascular Disease Risk Factors for Million Hearts 2022 — United States, 2011–2016. MMWR Morb Mortal Wkly Rep 2018;67:983–991. doi: http://dx.doi.org/10.15585/mmwr.mm6735a4
- 2 Tarn DM, Barrientos M, Pletcher MJ, et al. Perceptions of Patients with Primary Nonadherence to Statin Medications. The Journal of the American Board of Family Medicine. 2021;34(1):123-131. doi: https://doi.org/10.3122/jabfm.2021.01.200262
- CDC. Statins and Diabetes: What You Should Know. Centers for Disease Control and Prevention. Published January 30, 2023. https://www.cdc.gov/diabetes/library/features/Statins_Diabetes.html
- Kearney PM, Blackwell L, Collins R, et al.; Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008; 371:117–125
- Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019;140(11). doi: https://doi.org/10.1161/cir.0000000000000678
- Collins R, Reith C, Emberson J, et al. The Lancet. 2016;388(10059):2532-2561Interpretation of the evidence for the efficacy and safety of statin therapy. doi: https://doi.org/10.1016/S0140-6736(16)31357-5
- Hla D, Jones R, Blumenthal RS, et al. Assessing severity of statin side effects: Fact vs fiction. American College of Cardiology. April 09, 2018. Accessed May 17, 2023. https://www.acc.org/latest-in-cardiology/articles/2018/04/09/13/25/assessing-severity-of-statin-side-effects
- Reston JT, Buelt A, Donahue MP, Neubauer B, Vagichev E, McShea K. Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease. Annals of Internal Medicine. 2020;173(10):806-812. doi: https://doi.org/10.7326/m20-4680
- Brown M, Sinsky CA. Medication Adherence. Improve Patient Outcomes and Reduce Costs. American Medical Association Steps Forward. 5 June 2015. https://edhub.ama-assn.org/steps-forward/module/2702595. Accessed 16 May 2023
- Eight reasons patients don’t take their medications. American Medication Association. Feb 22, 2023. Accessed May 17, 2023. https://www.ama-assn.org/delivering-care/patient-support-advocacy/8-reasons-patients-dont-take-their-medications
- El Halabi J, Minteer W, Boehmer KR. Identifying and Managing Treatment Nonadherence. Medical Clinics of North America. 2022;106(4):615-626. doi: https://doi.org/10.1016/j.mcna.2022.02.003
Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BC-CR-069867-24-CPN69806 The Medicaid Medical Advisory Committee is recruiting diverse specialty physicians to serve as voting members and external consultants, offering insights on various topics. In these roles, physicians will attend regular meetings to review key metrics from the plan's Quality Management Program and Satisfaction Survey and assess peer review cases. Additionally, feedback is solicited regarding the adoption of the plan's Clinical Practice Guidelines. Meetings are held virtually on the last Wednesday of the second month of each quarter, starting at noon, with additional ad-hoc meetings conducted as needed. You are a valued member of our Medicaid network. If you are interested in learning more about this opportunity, please contact Danielle Frouws at Danielle.Frouws@elevancehealth.com. She will answer any questions for you and facilitate a discussion with Committee Chair Dr. Rafael Gonzalez-Amezcua, the plan’s medical director. In appreciation of your time and service, Anthem will provide an honorarium for each attended meeting. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-068162-24 At a glance:- Care providers must prepare for HEDIS® medical record reviews starting January 2025.
- Care providers will submit records through Remote Electronic Medical Record (EMR) Access Service, website upload, fax, secure file transfer protocol (SFTP), mail, or on-site.
BackgroundEach year, we perform a review of a sample of our members’ medical records as part of the HEDIS quality study. HEDIS is part of a nationally recognized quality improvement initiative and is used by the Centers for Medicare & Medicaid Services (CMS), the National Committee for Quality Assurance (NCQA), and several states to monitor the performance of managed care organizations. We will begin requesting medical records in January 2025. No special authorization is needed for you to share member medical record information with us since quality assessment and improvement activities are routine parts of healthcare operations. Ways to submit your records in our preferred order:- Remote EMR Access Service: We offer the Remote EMR Access Service to care providers to submit member medical record information to us. If you are interested in more information, contact us at Centralized_EMR_Team@anthem.com.
- Upload: Medical records can be uploaded to our secure website using the instructions in the request document.
- Fax: Medical records can be faxed to us using the instructions in the request document.
- SFTP: Medical records can be uploaded via a secure website.
- U. S. Postal Service: Medical records can be mailed to us using the instructions in the request document.
- On-site: Medical records can be pulled by a representative at your local office where medical records are located.
HEDIS review is time sensitive, so submit the requested medical records within the timeframe indicated in the initial HEDIS request document. We appreciate the care you provide our members. Your assistance is crucial to ensuring our data is statistically valid, auditable, and accurately reflects quality performance. Contact usAvaility Chat with Payer is available during normal business hours. Get answers to your questions about eligibility, benefits, authorizations, claims status, and more. To access Availity Essentials, go to https://Availity.com and select the appropriate payer space tile from the drop-down. Then, select Chat with Payer and complete the pre-chat form to start your chat. For additional support, visit the Contact Us section of our provider website for the appropriate contact. HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). Anthem Blue Cross is the trade name of Blue Cross of California. Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, Anthem BC Health Insurance Company, and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. CABC-CDCRCM-069931-24-CPN69632, CABC-CDCRCM-071167-24-CPN71157 The Consumer Assessment of Healthcare Providers and Systems® (CAHPS) is an annual standardized survey conducted anonymously by a third-party vendor (Center for the Study of Services) to assess a random sample of consumers' experiences with their health plan, their personal provider, and healthcare services. Refer to attachment to view full details. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc. CABC-CD-068361-24-CPN67980 ATTACHMENTS (available on web): Provider: CAHPS awareness (pdf - 0.07mb) |